McMaster University

McMaster University

Faculty of
Health Sciences

AstraZeneca

AstraZeneca

AstraZeneca, one of the largest pharmaceutical companies in the world, has a long-standing relationship with McMaster University and has invested more than $3 million to advance research and knowledge in the areas of gastroenterology and respirology. The research-oriented company that employs more than 66,000 people worldwide including 1,000 in Canada, has a wide product portfolio spanning six major therapeutic areas.

Its contributions to McMaster have allowed the establishment of both the Richard Hunt-AstraZeneca Chair in Gastroenterology and the AstraZeneca Chair in Epidemiology of Respiratory Diseases.

Officials of AstraZeneca said the company is proud to work with the University, and are confident their joint research initiatives will benefit people throughout the world.

Mike Cloutier, former president and CEO of AstraZeneca Canada Inc., said the initiatives with McMaster are helping expand Canada’s capacity for pharmaceutical research.

"It is only through the creation of such alliances and government policies that encourage innovation that Canada will be able to ensure its position at the forefront of global health care research."

[BACK]

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0